Transmedics Group Inc
NASDAQ:TMDX
Transmedics Group Inc
NASDAQ:TMDX
Price:
94.31
USD
-4.79%
Market Closed
Market Cap:
$3.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Transmedics Group Inc
NASDAQ:TMDX
|
US |
|
Amur Minerals Corp
LSE:AMC
|
RU |
|
C
|
CareTrust REIT Inc
NYSE:CTRE
|
US |
|
V
|
Vesuvius India Ltd
NSE:VESUVIUS
|
IN |
|
S
|
Southern Score Builders Berhad
KLSE:SSB8
|
HK |
|
Bexcellent Group Holdings Ltd
HKEX:1775
|
HK |
|
Sintex Plastics Technology Ltd
NSE:SPTL
|
IN |
|
Gene Biotherapeutics Inc
OTC:CRXM
|
US |
|
C
|
Cardno Ltd
OTC:COLDF
|
AU |
|
Northern Star Resources Ltd
ASX:NST
|
AU |
|
H
|
Hove A/S
CSE:HOVE
|
DK |
|
Mandarin Oriental International Ltd
SGX:M04
|
HK |
|
Novorossiyskiy Kombinat Khleboproduktov PAO
MOEX:NKHP
|
RU |
|
W
|
Wha Utilities and Power PCL
SET:WHAUP
|
TH |
Multiples-Based Value
The Multiples-Based Value of one
TMDX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 94.31 USD,
Transmedics Group Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TMDX Multiples-Based Value
LOCKED
Multiples Across Competitors
TMDX Competitors Multiples
Transmedics Group Inc Competitors
Transmedics Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Transmedics Group Inc
NASDAQ:TMDX
|
3.2B USD | 5.3 | 17 | 24 | 30 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.9B USD | 4 | 27.1 | 15.5 | 21.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.7B USD | 5 | 38.4 | 19.7 | 23.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110B USD | 3.1 | 23.9 | 13.2 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.3B USD | 4.6 | 32.2 | 19.1 | 25.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.2B USD | 7.6 | 43 | 23.6 | 25.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.4B USD | 10.3 | 41.9 | 29.7 | 32.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25.1 | 9.9 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 5.9 | 21.6 | 15.1 | 16.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
